Results 161 to 170 of about 110,471 (285)

Ultrasmall Au10–12 Nanoclusters: A Novel Platform for 223Ra‐Targeted Tumor α‐Therapy

Exploration, Volume 6, Issue 2, April 2026.
Encapsulating 223Ra in Au10‐12 nanoclusters and functionalizing them with RGD peptides enables targeted α‐therapy and immune microenvironment remodeling in non‐osseous tumors like triple‐negative breast cancer. This study establishes a foundational framework for novel 223Ra‐labeled α‐radiopharmaceuticals and shows strong potential for clinical ...
Yifei Jiang, Huizhen Yang, Guoping Jia, Wangxi Hai, Rongyi Huang, Peng Wang, Min Zhang, Danni Li, Yizhou Chen, Xiao Li, Biao Li, Chunfu Zhang   +11 more
wiley   +1 more source

Contemporary opportunities and potential of Auger electron-emitting theranostics. [PDF]

Theranostics
Lee SY, Manning HC.
europepmc   +1 more source

Alpha-emitting particles in lungs [PDF]

, 1975
Bair, W., Kellerer, Albrecht M., Stannard, J. N., Thompson, R. C.   +3 more
core   +2 more sources

25 Years of “Loop” Radiochemistry for PET Imaging

Journal of Labelled Compounds and Radiopharmaceuticals, Volume 69, Issue 4-6, April‐May 2026.
While conventional methods to 11C‐ and 18F‐labelled radiopharmaceuticals utilize a vial‐based approach, in the past quarter‐century, a modern, efficient, and cleaner “loop method” has been developed. The radiochemical diversity of reactions synthesized by the loop method are shown.
Emily Murrell, Sahil Khan, Neil Vasdev
wiley   +1 more source

Radiological risk assessment of natural radioactivity in imported rice consumed in Ghana and its implications for food safety and public health. [PDF]

Sci Rep
Dickson-Agudey P, Tettey-Larbi L, Adjei-Kyereme S, Lawluvi H, Asare EO, Osei RK, Ampene AA, Shahrokhi A.   +7 more
europepmc   +1 more source

Antibody–Drug Conjugates in Oncology: Principles, Clinical Development, and Future Directions

MedComm, Volume 7, Issue 4, April 2026.
Antibody–drug conjugates integrate antibody targeting with potent cytotoxic payloads to enable precision cancer therapy. Their clinical performance depends on coordinated optimization of engineering design, tumor antigen biology, and treatment strategy. Lessons from uro‐oncological malignancies illustrate how ADCs can be effectively developed, combined,
Bisheng Cheng, Lanqi Gong, Zongwei Wang, Peidan Peng, Kewei Xu, Hai Huang, Peng Wu   +6 more
wiley   +1 more source

Maternal geophagy in Ghana: a mini review of toxicological, microbial, nutritional, and radiological exposure pathways. [PDF]

Front Public Health
Lawluvi H, Arwui CC, Beinpuo ESW, Faanu A, Agyeman L, Akrobortu E, Amarh T.   +6 more
europepmc   +1 more source

Targeted Therapies for Each Subtype of Breast Cancer

MedComm, Volume 7, Issue 4, April 2026.
This review systematically summarizes the advances in targeted therapies for the three major molecular subtypes of breast cancer (BC), highlighting key strategies, agents, and clinical progress to guide personalized treatment. HR‐positive (luminal) BC: Dominated by estrogen receptor (ER) signaling, with endocrine therapies as the cornerstone—including ...
Aiyu Liu, Puchao Peng, Yeke Zhu, Qiuwen Fei, Weiwei Liu, Shizhen Zhang   +5 more
wiley   +1 more source

Radiological Hazard Assessment of Soil at North Oil Company Using Spatial Distribution and Monte Carlo Simulation in Kirkuk Governorate, Iraq. [PDF]

Sci Rep
Namq BF, Wais TY.
europepmc   +1 more source

Independent verification of vendor‐issued dosimetric data for 106Ru brachytherapy using diode detectors with traceability to external beam standards for absorbed dose to water

Medical Physics, Volume 53, Issue 4, April 2026.
Abstract Background Independent verification of the manufacturer‐provided dosimetry data for 106Ru ophthalmic brachytherapy applicators is crucial for safe and accurate treatment, yet a standardized, traceable method for clinical absolute dosimetry has been lacking. Purpose This work establishes a complete framework for traceable absorbed dose to water
Simon Dahlander, Ilias Billas, Thorsten Sander, Graham Bass, Linda Persson, Åsa Carlsson Tedgren   +5 more
wiley   +1 more source